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ORIGINAL ARTICLE

Intracranial Cavernous Angiomas

Syed Faraz Kazim, Atta-ul-Aleem Bhatti and Syed Ather Enam

ABSTRACT
Objective: To describe the clinical presentation, diagnosis, and management of patients presenting with intracranial
cavernous angiomas (CAs) at a tertiary care hospital in Pakistan.
Study Design: Case series.
Place and Duration of Study: Section of Neurosurgery, The Aga Khan University Hospital (AKUH), Karachi, from January
1990 to September 2008.
Methodology: A retrospective case note review of all patients diagnosed with intracranial CAs at AKUH during the study
period. The studied variables included patient demographics, clinical presentation, family history of intracranial CAs or
other space occupying lesions, modality of diagnosis, management, and outcome. Results were described as frequency
percentages.
Results: During the review period, 18 patients (11 males and 7 females) were diagnosed with intracranial CAs. The
median age at diagnosis was 28.5 years. The most common location of malformations was cerebrum (n=13) followed by
brain stem (n=3), and cerebellum (n=2). Nine patients had multiple lesions. Family history was present in 2 patients.
Seizures and focal neurologic deficits were the main clinical manifestations. The detection rate was 93.8% with magnetic
resonance imaging, but less with angiography and computerized tomography. Ten cases were treated surgically; 8 were
managed conservatively. The outcome was satisfactory except for one patient, who died within 6 months of diagnosis.
Surgery was performed for gross haemorrhage, rapidly increasing neurologic deficits, and intractable or long-standing
seizures.
Conclusion: Cavernomas tend to occur at younger age in females than males. This data raises a possibility of a higher
frequency of multiple cavernomas in Pakistani patients. The main clinical manifestations are seizures and focal neurologic
deficits. MRI is most sensitive and specific neuroradiologic modality for detecting this vascular malformation.
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INTRODUCTION
The four main central nervous system (CNS) vascular
malformations are arteriovenous malformations,
cavernous angiomas (CAs), venous angiomas, and
capillary telengiectasias.1 The intracranial CAs are well
circumscribed benign hamartomatous berry-like
collection of irregular thick and thin walled sinusoidal
vascular channels located within the brain but lacking
intervening neural parenchyma.2,3 They are usually
1-5 cm in size; multiple in 7-24% of patients.2,3 The
periphery of the lesions may contain cavernous lobules
invading adjacent brain tissue. Intracranial CAs have no
connective tissue capsule, but are usually well delimited
by peripheral gliosis. Thrombosis and haemorrhage may
occur within these lesions leading to calcification.
Cholesterol and haemosiderin deposits may also be
found.3,4 Since intracranial CAs are low flow vascular
lesions, their angiographic appearance is avascular, and
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they are classified as ‘cryptic’ or ‘angiographically occult’
CNS vascular malformations.3 Cavernous angiomas
comprise 5-13% of all CNS vascular malformations.4-7
They are usually located in supratentorial compartment
(70-80%), preferably in the white matter, but 10-20% are
located in the posterior fossa with a predilection for the
pons; 5-10% are found in the spine as well.4-7
Cavernous angiomas of the pineal region, cavernous
sinus, suprasellar region, third ventricle, lateral ventricle,
and dura have also been reported. 4-8 Intracranial
CAs are sporadic or hereditary. They are usually
asymptomatic, but when symptoms are present, they
depend on the location and size of the lesion. Seizures,
progressive neurologic deficits, and haemorrhage are
the most frequent clinical manifestations.4,6 Computerized
tomography (CT) and magnetic resonance imaging
(MRI) have proved to be useful diagnostic tools for
intracranial CAs. T2 weighted MRI is the most sensitive
test for the diagnosis of intracranial CAs.9,10 Surgical
excision is recommended for accessible lesions with
focal deficit or haemorrhage.11
Intracranial CAs have remained unexplored in Pakistan.
No clinical data is available regarding the clinical
manifestations, neuroradiology, and prognosis of
intracranial CAs in Pakistan. The aim of this study was
to describe experience with CAs of the brain at a tertiary
care hospital in Pakistan.
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METHODOLOGY
Cases of intracranial CAs were evaluated in a
retrospective, case note review of all patients presenting
with intracranial CAs at The Aga Khan University
Hospital (AKUH), Karachi, Pakistan, over a period of 18
years from January 1990 to September 2008. The
hospital’s computerized database with ICD-9-CM
(International classification of diseases, Ninth revision,
clinical modification) coding system was queried to
identify patients with intracranial CAs. The case notes of
all identified patients were retrieved and reviewed. All
data were collected on a proforma specifically designed
for the purpose. The study variables included patient
demographics, presenting signs and symptoms, comorbidities, family history of intracranial CAs or other
space occupying lesions, modality of diagnosis,
management, and outcome of treatment of particular
particular note were the indication for surgery. The
results were described in terms of descriptive statistics.

RESULTS
The hospital database revealed 18 patients [11 (61.1%)
males and 7 (38.9%) females] of intracranial CAs
admitted during 1990-2007. Majority of patients were in
the age group 21 - 35 years (12 out of 18, 66.67%). The
median age at presentation was 28.5 years (range 2 - 67
years).
Table I shows the symptomatic checklist, mode of
diagnosis, and outcome of each patient. Intracranial
CAs were located in the following sites: 13 in cerebral
hemispheres (4 each in frontal, temporal and parietal
lobes, 1 occipital lobe), 3 in the brain stem, 2 in the
cerebellum, 2 in the caudate nucleus and 1 each in the

basal ganglia, thalamus, cerebellopontine angle and
hypothalamus. Nine patients (50%) had multiple lesions.
Family history of intracranial CAs was present in 2
patients.
The clinical manifestations in 18 patients with intracranial
CAs were seizures (n=10, 55.5%), focal neurologic
deficits (n=8, 44.5%), headache (n=7, 38.8%), brain stem
syndromes (n=3, 16.7%), hemiplegia (n=1, 5.5%), and
cerebellar syndromes (n= 3, 16.7%). Haemorrhage
occurred in 6 (33.4%) of the cases. Two patients (Patient
16 and 18 in Table I) had a recurrent episode of
intracranial bleeding, 6 months and 2 months after the
initial haemorrhage respectively.
Only 1 of the 8 angiograms carried out showed specific
findings such as staining in the capillary phase while the
remaining 7 showed non-specific findings such as
vascular displacement and early drainage. Computed
tomography allowed detection in 5 out of the 10 patients
in whom it was used. Magnetic resonance imaging was
carried out in 16 out of 18 patients and revealed specific
findings of CAs in 15 (93.8%) patients and non-specific
in one patient.
Ten patients underwent surgical excision whereas
remaining 8 patients were managed conservatively.
Surgery was performed for gross haemorrhage, rapidly
increasing neurologic deficits, intractable or longstanding seizures. The outcome was good in all patients
except for one patient with multiple cavernomas in
cerebellum and in the region of fourth ventricle who died
within 6 months of diagnosis. This patient was managed
conservatively. The reason of death was cardiopulmonary arrest. No mortality was noted in the patients
who were treated surgically.

Table I: Clinical characteristics of 18 patients with intracranial cavernous angiomas.
Case

Gender

Location of lesion(s)

Presenting signs and symptoms

1
2
3

Age
(years)
28
27
30

Female
Male
Female

Caudate nucleus
Frontal lobe, cerebral peduncles
Brain stem

4
5

23
62

Female
Male

6
7
8

35
65
27

Male
Male
Male

9
10
11
12
13
14
15

26
2
33
67
58
27
7

Female
Male
Female
Male
Male
Male
Male

Hypothalamus
Cerebello-pontine angle,
fourth ventricle
Parietal lobe
Parietal and occipital lobes
Temporal lobe, basal ganglia,
thalamus
Caudate nucleus, lateral ventricle
Parietal lobe
Cerebellum, fourth ventricle
Temporal lobe
Frontal lobe
Temporal lobe
Frontal and parietal lobes

Seizures, headache
Headache, Right-sided weakness
Weakness of cranial nerves
VII, VIII, and IX
Headache
Dizziness, slurred speech,
severe vomiting, in coordination
Headache
Seizures, left-sided weakness
Seizures

16
17

29
28

Female
Male

Temporal lobe
Brain stem, cerebellum

18

31

Female

Brain stem

Seizures, headache, weakness
Seizures
Incoordination
Seizures, right-sided weakness
Seizures, left lower limb weakness
Seizures, fainting episodes
Seizures, hemiplegia
Seizures, headache
Headache, Left sided cranial
nerve VII palsy
Right-sided weakness, cranial
nerves VII, VIII, and IX palsies

Duration of
symptoms
3 years
1 year
6 months

Mode of diagnosis Management Outcome
MRI
MRI
CT

Conservative Good
Surgical
Good
Conservative Good

1 year
2 years

MRI
CT and MRI

Conservative Good
Surgical
Good

3 years
1 month
2 months

MRI
CT
MRI

Surgical
Good
Conservative Good
Conservative Good
Conservative
Surgical
Conservative
Conservative
Surgical
Surgical
Surgical

Good
Good
Expired
Good
Good
Good
Good

1 year
2 months

MRI
MRI
MRI
CT and MRI
MRI
MRI
Angiography,
CT, and MRI
MRI
MRI

Surgical
Surgical

Good
Good

7 months

MRI

Surgical

Good

4
7
3
5
15
7
2

years
days
months
years
days
years
days

Abbreviations: CT=Computed tomography; MRI=Magnetic resonance imaging.
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Table II: Current series in the context of published literature on intracranial cavernous angiomas.
Authors (reference)

M/F

Location of lesions

Clinical features

Mode of diagnosis

Treatment

Requena et al.14

No. of
cases
47

21/26

35

25/10

Seizures=16, brainstem
syndromes=14, focal neurologic
deficits=5, SAH=1, cerebellar
syndromes=2, intra- cranial
hypertension=1,spastic
paraparesis=1
Headache=18, seizures=13,
focal neurological deficits=9,
brain stem syndromes=2

Pozatti et al.12

18

5/13

Cerebral hemispheres
(FL=4, TL=1, PL=1, OL=1),
thalamus=4, cerebellum=3,
diencephalon=2, caudate
nucleus=2 brain stem=1.

Hemiparesis=6, Seizures=4,
acute cerebellar syndrome=3,
hemisensory deficit=1, brain
stem syndrome=1, hypothalamic
syndrome=1, asymptomatic=1.

No detection with 24 angiograms
done, CT-scan detected in
40 of 45 patients in whom it
was used, MRI showed 56
cavernomas in 47 patients studies,
6 had multiple lesions
Angiography detected 3 cases
out of 28 in whom it was done,
CT 10 out of 26, and MRI 26
out of 28.
Angiography negative in all;
all cases detected by CT and MRI

Surgical removal
performed in 18
cases.

Attar et al.11

Cerebral hemisphere
(FL=4, TL=13, PL=8,OL=2),
pons=10, cerebellum=6,
thalamus=4, cerebral
peduncles=4, medulla=2,
spinal cord=1
Cerebral hemisphere=21,
Cerebellum=6, thalamus=4,
lateral ventricle=4

Wurm et al.25

15

8/7

Seizures=9, headache=2,
dizziness=2, ataxia=1,
asymptomatic=1.

All cases detected by MRI.

Current series

18

11/7

Cerebral hemispheres
(FL=3, TL=5, OL=1),
insular cortex=2, brain
stem=1, cerebellum=1,
paraventricular=1,
caudate nucleus=1.
Cerebral hemispheres
(FL=4, TL=4, PL=4,
OL=1), brain stem=3,
cerebellum=2, caudate
nucleus=2, basal ganglia=1,
thalamus=1, cerebellopontine
angle=1, hypothalamus=1.

Seizures=10, focal neurological
deficits=8, headache=7, brain
stem syndromes=3, cerebellar
syndromes=3, hemiplegia=1

Angiography detected 1 out of 8,
CT 5 out of 10, and MRI 16
out of 18 in whom carried out

Surgical removal
in all 35; good
outcome in 34
patients, 1 died.
Surgical removal
in 12, conservative
management in 6.
Good outcome in
10 patients, minor
deficit in 6, 1
dependent, 1 died.
Surgical resection
in all 15;
recurrence in 3
cases.

Surgical excision
in 10 cases;
conservative
management in 8.
Good outcome in
all except one who
died.

Abbreviations: FL=Frontal lobe, TL=Temporal lobe, PL=Parietal lobe, OL=Occipital lobe

The MRI scans of a patient with CA in the parietal lobe
(patient number 10 in the Table I) are shown in Figure 1.
Table II compares the results of this study with some of
the previously published case series of intracranial CAs.

a

b

Figure 1a and b: Magnetic resonance imaging demonstrating the
intracranial cavernous angioma in the right parietal lobe as a hyper intense
lesion surrounded by edema in contrast-enhanced T1 weighted images
(arrows). Flow voids can be identified in the periphery of the lesion. The
scans are of Case no. 10 in Table I.

DISCUSSION
Intracranial CAs belong to a group of vascular malformations that are developmental malformations of the
vascular bed. They consist of thin walled sinusoids with
no intervening neural tissue. These congenital vascular
malformations frequently enlarge over time. The growth
patterns of intracranial CAs are mainly related to
repeated intralesional haemorrhage and thrombosis,
to the expansion of haemorrhagic cyst cavities, to the
deposition of haemosideric pigments, and to the
740

reactive gliosis that enlarges with time.2,12,13 Intracranial
CAs vary from several millimeters to several centimeters
(usually < 3 cm) in diameter.
Familial occurrence has been reported by some studies
in up to 50% of patients.1-3 However, other studies have
found a lower occurrence of familial intracranial CAs.
Requena et al. have reported a 4.3% incidence of familial
cavernomas.14 Similarly Attar et al. reported that only
one patient in their series of 35 intracranial CAs patients
had a familial occurrence.11 Family history of intracranial
CAs was found in 2 out of 18 (11%) patients in current
series. The vast difference in various studies regarding
the familial occurrence can also be attributed to
methodological issues. With retrospective chart note
reviews, like this case series, there is always a chance
of underestimation of variables like familial occurrence,
because these studies do not systematically investigate
the families of the patients. Family screening has been
reported to increase the number of diagnosis of familial
cavernomas.15
Past studies have reported the incidence of intracranial
CAs to be equal for either gender,5 greater in males than
females,16 and greater in females than males.17 In the
current series, the number of males (n=11, 61%) was
more than the number of females (n=7, 39%). Requena
et al. have reported a trend of an earlier clinical
manifestation in young male patients.14 In their study,
52% of male patients were diagnosed before the age of
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30 years, compared with only 11.5% of female patients.
In the present series, 6 (54.5%) of male patients were
diagnosed before the age of 30 years, whereas 4 (57%)
of female patients were diagnosed with age less than 30
years. However, none of the females in this series were
more than 40 years of age as compared to male cases,
among which 2 were in 50s and 2 in 60s. Hormonal
factors have been speculated to play some role in the
biology of cavernomas.12,14 The metabolic activity of
cerebral CAs can be altered by estrogens, which may
induce platelet-mediated thrombosis.18 Recent findings
indicate that the growth and the progression of
the clinical picture of hemanioblastomas may be
accelerated by sex hormones.12,18 The size of
cavernous malformations is known to increase during
pregnancy and to decrease after delivery.19 The
increase in the blood volume occurring during
pregnancy might be an important factor in angioma
rupture.6 However, endocrine factors may influence their
haemorrhagic tendency, particularly in the first trimester,
which is characterized by vascular proliferation of the
endometrium associated with secretion of human
chorionic gonadotropin, progesterone, and estrogen.20
The haemorrhagic capacity of intracranial CAs is
obvious. Acute gross haemorrhage, small subclinical
bleeding, or even slow extravasation of red blood cells
may occur.12 It is known that CAs may be found
incidentally during surgery in patients who apparently
have intracerebral hematomas.21 There is also a risk of
subsequent haemorrhage after the initial bleeding.
Pozzati et al. have reported the recurrence duration from
1 week to 3 years, with a median time of 11 months.12
Others have also reported an interval from initial
haemorrhage to first recurrence ranging from 1 to 60
months (average, 12 months).22 Six out of 18 patients, 4
females and 2 males, in this series had haemorrhage.
Recurrence occurred in 2 patients (both females) with a
duration range of 2-6 months. Zimmerman et al. have
reported a series of 16 patients (13 females and 3
males) with brain stem cavernous malformations
characterized by repeated bleeding that sometimes
occurred in the weeks ensuing the first haemorrhage.23
The patient in this series who had a recurrent episode of
bleeding within 2 months had also a brain stem
cavernoma.
The reported incidence of multiple intracranial CAs is
7-24%.1-3 Nine out of 18 (50%) patients in this series
had multiple lesions. Our data raises a possibility of a
higher incidence of multiple intracranial CAs in this part
of the world. However, a single center data is not
sufficient to justify such claims. We need similar reports
from other centers to verify this finding.
The location of intracranial CAs has been speculated to
play a role in the natural behaviour of CAs. Cavernomas
of the third ventricle sometimes demonstrate rapid

and extensive growth; a possible explanation is strong
hormonal influence due to the site.19 The high mortality
of brain stem and basal ganglia CAs can be related
to the high sensitivity of these regions even to small
bleedings.12
The clinical manifestations of cavernous angiomas are
reported to be seizures in 60-70% of the cases,
headache in 25-50%, progressive neurological deficits
in 20-50%, and haemorrhage in < 20%.5,16 In this study,
there were seizures in 55.5%, focal neurologic deficits in
44.5%, headache in 38.8%, brainstem syndromes in
16.7%, cerebellar syndromes in 16.7% and haemiplegia
in 5.5%. The location of the cavrenomas generally
correlated well with the clinical presentations. Majority of
the present patients had supra tentorial lesions;
seizures were thus the most common clinical
manifestation in this series. A solitary cavernoma in the
hypothalamus, however, interestingly presented with
headache only, no hypothalamic or pituitary dysfunction
was noted.
Most cavernous malformations are angiographically
occult, and when they are evident on angiograms, the
findings are non-specific.14,16 Although intracranial CAs
may be apparent and can be diagnosed with CT scans,
it is not the imaging modality of choice.9,10 Computed
tomography findings are compatible not only with
intracranial CAs but also with low-grade tumours, among
other entities.9,10 The sensitivity of MRI to flowing blood
and blood products of varying ages, as well as the
greater contrast resolution of MRIs, greatly increases
the specificity of MRI compared with that of CT.10,24
Combining multiple MRI sequences has largely
eliminated misdiagnosis of intracranial CAs, because
they have relatively specific signal characteristics.
Additionally, gradient - echo imaging, with its increased
sensitivity to susceptibility artifact, is useful in the
detection of smaller and concomitant lesions, which may
not be detected with traditional sequences.10,24
Computed tomography and magnetic resonance
imaging can both be used in the follow-up monitoring of
patients with known intracranial CAs, particularly when
haemorrhagic events are suspected.10,24 Although the
MRI appearance of intracranial CAs is not helpful in
predicting future bleeds, MRI is the method of choice for
the long-term follow-up of patients with intracranial CAs
and for the assessment of family members in whom
similar lesions are suspected.24 In addition, MRI is
extremely helpful in pre-surgical planning to assess the
extent of the lesion, define borders, and plan the surgical
approach and exposure.24
All patients in this series underwent neuroradiological
studies including angiography, CT, and MRI; sometimes
multiple modalities were used. Angiography failed to
reveal cavernoma in 7 of the 8 cases in which it was
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performed. The CT scan was not always diagnostic,
whereas MRI showed typical features of cavernomas in
93.8% of the patients in whom it was used.
Surgical removal of intracranial CAs is recommended for
intractable seizures, rapidly increasing neurological
deficits, and also to prevent gross haemorrhage and
lesion growth.11,25 Surgical excision of an intracranial CA
prevents its growth, and thus terminates the related
clinical manifestations. It also helps in confirming the
diagnosis when there are doubts regarding the
underlying pathology.11,25 Ten patients in this series
underwent surgical removal of intracranial CAs, with
modest outcomes.
This series of 18 intracranial CA cases is the largest by
far from pakistan. This small number for a 19 years
record at one of the largest tertiary care hospital in
Pakistan suggests that either the prevalence of
intracranial CAs is low in the country, or that the disorder
is seldom brought to clinical attention. The latter could
be supported on the grounds that Pakistan, like its
neighbouring regions, is burdened with the wrath of
communicable diseases, which are responsible for the
major share of infant, childhood, and adult mortality,
and hence obscure the actual incidence of noncommunicable diseases.

CONCLUSION
Intracranial cavernous angiomas are developmental
malformations of the vascular bed. Familial occurrence
is variable. Although, there may not be any specific
gender predilection, but hormonal factors may play a
role in the biology of intracranial CAs. The number of
multiple lesions was noted to be higher in this series as
compared to reports from other geographical areas.
Seizures, focal neurological deficits, headache, and
haemorrhage constitute the most common clinical
manifestations and indeed the reasons for surgery.
Angiography is unsuitable for detecting this vascular
malformation. Magnetic resonance imaging remains the
modality of choice, with high sensitivity and specificity
for detecting intracranial CAs.
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